Aclarion Completes Reverse Stock Split to Meet Nasdaq Listing Standards
Aclarion, Inc. completes a reverse stock split to meet Nasdaq listing standards, leveraging Magnetic Resonance Spectroscopy to optimize clinical treatments and identify chronic low back pain.
This news matters as it highlights Aclarion's efforts to maintain its Nasdaq listing by increasing its share price. The reverse stock split will impact shareholders and assist in the Company's goal to optimize clinical treatments for chronic low back pain.
